"UC Davis Health was one of the first institutions in the country to get this designation and remains the only university-based NAPRC accredited program in Northern California,” said chief of colorectal surgery Ankit Sarin. “Our reaccreditation, under the leadership of Assistant Professor Miquell Miller, is a testament to our continued commitment to the highest quality of care for our cancer patients."
Miller, a surgeon, is director of the cancer center’s rectal cancer tumor board and assistant director of its Office of Inclusivity, Diversity, Equity and Accessibility (IDEAL).
ACS quality improvement assessments are grounded in more than a century of experience and are an important measure of a hospital’s surgical quality. The designation follows similar accreditation earned by the UC Davis Medical Center and UC Davis Comprehensive Cancer Center.
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 100,000 adults and children every year and access to more than 200 active clinical trials at any given time. Its innovative research program engages more than 240 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Office of Community Outreach and Engagement addresses disparities in cancer outcomes across diverse populations, and the cancer center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists. For more information, visit cancer.ucdavis.edu.
